Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

NCT06888193 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT06888193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06888193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Lead sponsor
UCB Biopharma SRL
Phase
Phase 1
Overall status
Recruiting
Start date
November 5, 2025
Completion date
December 31, 2027
Enrollment
20 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

axial spondyloarthritis, hidradenitis suppurativa, moderate to severe plaque psoriasis, psoriatic arthritis